Profiles for companies starting with 'e'
✉ Email this page to a colleague
Drugs and US Patents for e
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-002 | Nov 20, 2020 | RX | Yes | Yes | 8,828,356 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Exela Pharma | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 018925-001 | Mar 30, 1984 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eisai Inc | BANZEL | rufinamide | SUSPENSION;ORAL | 201367-001 | Mar 3, 2011 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Elite Labs Inc | DANTROLENE SODIUM | dantrolene sodium | CAPSULE;ORAL | 076686-002 | Oct 24, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |